Condition: Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) · Sponsor: Universitaire Ziekenhuizen KU Leuven
The goal of this study is to calculate pharmacokinetic parameters and to evaluate the trough levels of posaconazole reached in patients with different stages of mucositis, due to chemotherapy and total body irradiation.
This description comes directly from the study's public registry record.
Kim Vanstraelen, R.Ph. · (+32) (0)16342339 · kim.vanstraelen@uzleuven.be
Isabel Spriet, Pharm.D. · isabel.spriet@uzleuven.be
Always discuss trial participation with your own doctor first.
| University Hospitals Leuven | Leuven, Vlaams-Brabant, Belgium | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT01420562